Overview
Glycogen storage disease due to muscle phosphorylase kinase deficiency (also known as GSD type IXd or muscle-specific phosphorylase kinase deficiency) is a rare inherited metabolic disorder affecting skeletal muscle. Phosphorylase kinase is a key enzyme that activates glycogen phosphorylase, which is responsible for breaking down glycogen into glucose for energy use. When this enzyme is deficient specifically in muscle tissue, glycogen accumulates abnormally in skeletal muscle cells, impairing the muscle's ability to generate energy during exercise. Affected individuals typically present with exercise intolerance, muscle cramps, myalgia (muscle pain), and fatigue, particularly during vigorous physical activity. Some patients may experience episodes of myoglobinuria (dark-colored urine due to muscle breakdown) following strenuous exercise, which in severe cases can lead to acute kidney injury. Muscle weakness may be mild and progressive. The severity of symptoms can vary considerably among affected individuals. Onset is generally in childhood or adolescence, though milder cases may not be recognized until adulthood. Phosphorylase kinase is a complex enzyme composed of four subunits (alpha, beta, gamma, and delta), and mutations in different subunit genes can cause tissue-specific or generalized forms of phosphorylase kinase deficiency. The muscle-specific form (GSD IXd) is caused by mutations in the PHKA1 gene (encoding the muscle-specific alpha subunit), which is located on the X chromosome, making this form X-linked recessive. Management is primarily supportive and includes avoidance of intense anaerobic exercise, dietary modifications to ensure adequate energy supply, and careful monitoring of kidney function during episodes of rhabdomyolysis. A high-protein diet and moderate aerobic exercise conditioning may be beneficial. There is currently no specific curative treatment available.
Also known as:
Clinical phenotype terms— hover any for plain English:
X-linked recessive
Carried on the X chromosome; typically affects males more than females
Variable
Can begin at different ages, from infancy through adulthood
Treatments
No FDA-approved treatments are currently listed for Glycogen storage disease due to muscle phosphorylase kinase deficiency.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Glycogen storage disease due to muscle phosphorylase kinase deficiency at this time.
New trials open frequently. Follow this disease to get notified.
Specialists
View all specialists →No specialists are currently listed for Glycogen storage disease due to muscle phosphorylase kinase deficiency.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Glycogen storage disease due to muscle phosphorylase kinase deficiency.
Community
No community posts yet. Be the first to share your experience with Glycogen storage disease due to muscle phosphorylase kinase deficiency.
Start the conversation →Latest news about Glycogen storage disease due to muscle phosphorylase kinase deficiency
No recent news articles for Glycogen storage disease due to muscle phosphorylase kinase deficiency.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Glycogen storage disease due to muscle phosphorylase kinase deficiency
What is Glycogen storage disease due to muscle phosphorylase kinase deficiency?
Glycogen storage disease due to muscle phosphorylase kinase deficiency (also known as GSD type IXd or muscle-specific phosphorylase kinase deficiency) is a rare inherited metabolic disorder affecting skeletal muscle. Phosphorylase kinase is a key enzyme that activates glycogen phosphorylase, which is responsible for breaking down glycogen into glucose for energy use. When this enzyme is deficient specifically in muscle tissue, glycogen accumulates abnormally in skeletal muscle cells, impairing the muscle's ability to generate energy during exercise. Affected individuals typically present with
How is Glycogen storage disease due to muscle phosphorylase kinase deficiency inherited?
Glycogen storage disease due to muscle phosphorylase kinase deficiency follows a x-linked recessive inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.